BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• UCB Presents New Findings Advancing Patient Care for Chronic Inflammatory Diseases and Osteoporosis at 2017 ACR/ARHP Annual Meeting

  Study findings suggest that opioids are vastly overprescribed as a treatment for pain associated with AS, often in lieu of more effective treatments such as anti-TNFs and NSAIDs.

  November 7, 2017

   · 

  22 min read
• Business

  Protagonist Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  Protagonist Therapeutics today reported its financial results for the third quarter and nine months ended September 30, 2017 and provided an update on the company’s recent achievements.

  November 7, 2017

   · 

  14 min read
• CryoLife Announces Enrollment of First Patients in BioGlue Clinical Trial in China

  The results from the trial will serve as the basis of the Company’s regulatory submission to the CFDA to gain approval to commercialize BioGlue in China. Patients are currently being enrolled at multiple heart centers in China.

  November 7, 2017

   · 

  4 min read
• Biotech Bay

  Impax Announces Successful Completion of Consent Solicitation With Respect to its 2.00% Convertible Senior Notes Due 2022

  Impax Labs announced today that it has received the consents necessary to amend and insert certain provisions in the indenture dated as of June 30, 2015 between the Company and Wilmington Trust, National Association, as trustee, governing its 2.00% Convertible Senior Notes due 2022.

  November 7, 2017

   · 

  5 min read
• Business

  NeuroVive Board Chair Resigns, New Chair Elected

  NeuroVive announces that Gregory Batcheller resigned as Chair of the NeuroVive Pharmaceutical AB Board effective midnight November 6, 2017.

  November 7, 2017

   · 

  4 min read
• TherapeuticsMD Announces Third Quarter 2017 Financial Results

  Net revenue from the company’s prescription prenatal vitamin business was approximately $4.4 million for the third quarter of 2017 compared with net revenue of approximately $5.5 million for the prior year’s quarter.

  November 7, 2017

   · 

  10 min read
• Genetown

  Insulet Announces Private Offering $300M of Convertible Senior Notes

  Insulet announced its intention to offer, subject to market and other conditions, $300 million principal amount of convertible senior notes due 2024 (the Notes) in a private placement.

  November 7, 2017

   · 

  3 min read
• Business

  IntriCon Reports 2017 Third-Quarter Results

  For the 2017 third quarter, the company reported net sales of $24.0 million, up 54.4 percent from $15.6 million in the prior-year period.

  November 7, 2017

   · 

  13 min read
• Business

  McKesson Strengthens Its Portfolio of Manufacturer Solutions With the Acquisition of RxCrossroads

  McKesson Corporation today announced that it has signed a definitive agreement to purchase RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health Corporation (NYSE:CVS).

  November 7, 2017

   · 

  6 min read
• Business

  Myomo Reports Third Quarter 2017 Results

  Total revenue for the third quarter increased 165% year over year to $489,000, compared to $184,000 for the third quarter of 2016.

  November 7, 2017

   · 

  15 min read